Sequenom Delays Launch Of Down Syndrome Test By: MarketMinute.com Stock News April 30, 2009 at 13:42 PM EDT Shares of Sequenom Inc. (Nasdaq: SQNM) collapsed $11.27 to $3.64 after the company delayed the launch of its Down syndrome test.